vascular [bpoc]
Protection [fndg]
Renal Failure [dsyn]
Accelerated [ftcn]
Atherosclerosis [dsyn]
One [qnco]
Primary [qlco]
Morbidity [qnco]
Mortality [qnco]
Patients [podg]
Chronic Kidney Diseases [dsyn]
Multiple [qnco]
Factor [ftcn]
High Risk [qlco]
CV [idcn]
High Prevalence [qnco]
Traditional [ftcn]
CV [idcn]
risk factors [qnco]
Anaemia [dsyn]
Hyperphosphataemia [dsyn]
Hyperparathyroidism [dsyn]
Vascular calcifications [patf]
endothelial dysfunction [dsyn]
Arterial [bpoc]
Thickness [qlco]
Present [qnco]
Renal Failure [dsyn]
General Population [popg]
vascular [bpoc]
Protection [fndg]
CORRECTION [inpr]
CV [idcn]
risk factors [qnco]
General Population [popg]
Treatment Efficacy [qlco]
Often [tmco]
Absent [qnco]
Chronic Kidney Diseases [dsyn]
Population [qnco]
Specific [qlco]
Factor [ftcn]
Anaemia [dsyn]
Corrected [qlco]
Excess [qlco]
Control [grup]
PREVENT [phsu]
Vascular calcification [patf]
Best [qlco]
treatment [ftcn]
Vitamin D [orch, phsu, vita]
Uptake [phsf]
Contribute [acty]
To [qlco]
limit [ftcn]
Hyperparathyroidism [dsyn]
Survival [acty]
Dialysis [npop]
Patients [podg]
High dose [qnco]
FAVOR [orch, phsu, vita]
Hypercalcaemia [dsyn]
ONGOING [idcn]
Trial [resa]
Test [lbpr]
Vascular calcifications [patf]
cardiovascular events [fndg]
Chronic Kidney Diseases [dsyn]
Patients [podg]
Additional [ftcn]
Therapeutic [topp]
Target [ftcn]
Identified [qlco]
Novel [tmco]
Drug Development [bmod]
